Evidence map›Paper›PMID 38417478›Full record

ArticleProgress in neuro-psychopharmacology & biological psychiatry2024

Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice.

Jenny L Wiley, Julie A Marusich, Bruce E Blough, Ojas Namjoshi, Marcus Brackeen, Luli R Akinfiresoye, Teneille D Walker, Cassandra Prioleau, Daniel G Barrus, Thomas F Gamage

Open access · greenAbstract read
In one paragraph

Article in Progress in neuro-psychopharmacology & biological psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Derivation of a health-based guidance value for ΔEFSA journal. European Food Safety Authority · 2025
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jenny L WileyRTI International, Research Triangle Park, NC, USA.
Julie A MarusichRTI International, Research Triangle Park, NC, USA. Electronic address: jmarusich@rti.org.
Bruce E BloughRTI International, Research Triangle Park, NC, USA.
Ojas NamjoshiRTI International, Research Triangle Park, NC, USA.
Marcus BrackeenRTI International, Research Triangle Park, NC, USA.
Luli R AkinfiresoyeUnited States Department of Justice, Drug Enforcement Administration, Diversion Control Division, Drug and Chemical Evaluation Section, 8701 Morrissette Drive, Springfield, VA, USA.
Teneille D WalkerUnited States Department of Justice, Drug Enforcement Administration, Diversion Control Division, Drug and Chemical Evaluation Section, 8701 Morrissette Drive, Springfield, VA, USA.
Cassandra PrioleauUnited States Department of Justice, Drug Enforcement Administration, Diversion Control Division, Drug and Chemical Evaluation Section, 8701 Morrissette Drive, Springfield, VA, USA.
Daniel G BarrusRTI International, Research Triangle Park, NC, USA.
Thomas F GamageRTI International, Research Triangle Park, NC, USA; Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA.
RTI International · USDrug Enforcement Administration · US

Funding

Minor Cannabinoids and Terpenes: Preclinical Evaluation as AnalgesicsR01AT010773 · NCCIH · UPSTATE MEDICAL UNIVERSITY · PI GAMAGE, THOMAS F · 2019 to 2024
$2.5M
In vitro and in vivo characterization of CB1 allosteric modulatorsK01DA045752 · NIDA · UPSTATE MEDICAL UNIVERSITY · PI GAMAGE, THOMAS F · 2018 to 2022
$807k
NCCIH NIH HHS R01 AT010773NIDA NIH HHS K01 DA045752
6 · The paper itself

Abstract

backgroundThe cannabis plant contains several cannabinoids, and many terpenoids that give cannabis its distinctive flavoring and aroma. Δ

methodsΔ

resultsAll minor cannabinoids showed measurable cannabinoid 1 (CB

conclusionIn summary, only some of myriad cannabinoids and other chemicals found in the cannabis plant bind potently to the identified cannabinoid receptors. Further, only four of the compounds tested herein [Δ

Indexed as

CannabidiolCannabinoidsCannabisAnimalsCannabinolDronabinolMiceTerpenescannabichromeneCannabidiolCannabinoidsCannabinolDronabinolTerpenesCannabidiolCannabinolDrug discriminationTetrahydrocannabinolTHCVβ-Caryophyllene

Identifiers

PMID38417478
PMCPMC11015967
OpenAlexW4392203357

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.